This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/521893-china-vaccination-covid19-supply/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
China administers more than 210 million Covid-19 vaccines, despite supply challenges China administers more than 210 million Covid-19 vaccines, despite supply challenges
(about 2 months later)
China has now administered more than 210 million vaccines to protect its citizens against Covid-19, a figure only surpassed by the US, despite state officials talking about a shortage of shots in some regions.China has now administered more than 210 million vaccines to protect its citizens against Covid-19, a figure only surpassed by the US, despite state officials talking about a shortage of shots in some regions.
In a daily update published on Friday, the Chinese health authorities announced that 211 million vaccines had been administered across the country as of April 22. The figure is equivalent to around 14 doses per 100 people, although some individuals have already had their second shot. In a daily update published on Friday, the Chinese health authorities announced that 211 million vaccines had been administered across the country as of April 22. The figure is equivalent to around 14 doses per 100 people, although some individuals have already had their second shot. 
In terms of the total number of vaccines dispensed, China’s figure is only bettered by the US where 219 million jabs have been administered. This equates to 64 doses per 100 people. Approximately 90 million of the shots given out in the US have been second doses. In terms of the total number of vaccines dispensed, China’s figure is only bettered by the US where 219 million jabs have been administered. This equates to 64 doses per 100 people. Approximately 90 million of the shots given out in the US have been second doses. 
Earlier this week, Zheng Zhongwei, director of the Development Center for Medical Science and Technology of the National Health Commission (NHC), admitted China was battling to overcome vaccine shortages in some regions but said domestic supply should increase in the coming months. Earlier this week, Zheng Zhongwei, director of the Development Center for Medical Science and Technology of the National Health Commission (NHC), admitted China was battling to overcome vaccine shortages in some regions but said domestic supply should increase in the coming months. 
“At present, domestic vaccine supply is relatively tight, but from May, especially after June, the vaccine supply situation will ease significantly,” he said. Zheng told the Global Times that China hopes to produce 3 billion Covid-19 shots this year and increase production capacity to 5 billion. “At present, domestic vaccine supply is relatively tight, but from May, especially after June, the vaccine supply situation will ease significantly,” he said. Zheng told the Global Times that China hopes to produce 3 billion Covid-19 shots this year and increase production capacity to 5 billion. 
The Global Times reported vaccine shortages in Hainan Province, Guangdong Province and Shaanxi Province earlier in April, with a number of health authorities delaying administering second jabs or closing inoculation facilities completely. The state-run news agency said China intends to vaccinate about 560 million people by the end of June.The Global Times reported vaccine shortages in Hainan Province, Guangdong Province and Shaanxi Province earlier in April, with a number of health authorities delaying administering second jabs or closing inoculation facilities completely. The state-run news agency said China intends to vaccinate about 560 million people by the end of June.
If you like this story, share it with a friend!If you like this story, share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.